关注
jim xiang
jim xiang
University of Saskatchewan, University of Toronto, University of Florida
在 usask.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity
S Hao, O Bai, F Li, J Yuan, S Laferte, J Xiang
Immunology 120 (1), 90-102, 2007
3072007
HER2-directed therapy: current treatment options for HER2-positive breast cancer
S Ahmed, A Sami, J Xiang
Breast cancer 22, 101-116, 2015
2442015
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells
Z Chen, T Moyana, A Saxena, R Warrington, Z Jia, J Xiang
International journal of cancer 93 (4), 539-548, 2001
2162001
A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells
J Xiang, H Huang, Y Liu
The Journal of Immunology 174 (12), 7497-7505, 2005
1912005
Mechanisms of cellular communication through intercellular protein transfer
KA Ahmed, J Xiang
Journal of cellular and molecular medicine 15 (7), 1458-1473, 2011
1762011
Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes
S Hao, O Bai, J Yuan, M Qureshi, J Xiang
Cell Mol Immunol 3 (3), 205-211, 2006
1702006
Membrane‐bound HSP70‐engineered myeloma cell‐derived exosomes stimulate more efficient CD8+ CTL‐ and NK‐mediated antitumour immunity than …
Y Xie, O Bai, H Zhang, J Yuan, S Zong, R Chibbar, K Slattery, M Qureshi, ...
Journal of cellular and molecular medicine 14 (11), 2655-2666, 2010
1642010
CD4+ T cell-released exosomes inhibit CD8+ cytotoxic T-lymphocyte responses and antitumor immunity
H Zhang, Y Xie, W Li, R Chibbar, S Xiong, J Xiang
Cellular & molecular immunology 8 (1), 23-30, 2011
1472011
Intercellular trogocytosis plays an important role in modulation of immune responses
KA Ahmed, MA Munegowda, Y Xie, J Xiang
Cellular & molecular immunology 5 (4), 261-269, 2008
1422008
Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated …
Y Xie, H Zhang, W Li, Y Deng, MA Munegowda, R Chibbar, M Qureshi, ...
The Journal of Immunology 185 (9), 5268-5278, 2010
1412010
Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
S Hao, Z Ye, F Li, Q Meng, M Qureshi, J Yang, J Xiang
Experimental oncology 28 (2), 126-131, 2006
1382006
Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy
Z Fu, J Xiang
International Journal of Molecular Sciences 21 (23), 9123, 2020
1262020
Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity
M Ankathatti Munegowda, Y Deng, SJ Mulligan, J Xiang
Cancer Immunology, Immunotherapy 60, 1473-1484, 2011
1252011
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I …
H Huang, S Hao, F Li, Z Ye, J Yang, J Xiang
Immunology 120 (2), 148-159, 2007
1122007
IFN-γ down-regulates ABCA1 expression by inhibiting LXRα in a JAK/STAT signaling pathway-dependent manner
X Hao, D Cao, Y Hu, X Li, X Liu, J Xiao, D Liao, J Xiang, C Tang
Atherosclerosis 203 (2), 417-428, 2009
1082009
CD4− 8− dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity
X Zhang, H Huang, J Yuan, D Sun, WS Hou, J Gordon, J Xiang
The Journal of Immunology 175 (5), 2931-2937, 2005
1062005
Advances in dendritic cell-based vaccine of cancer
X Zhang, JR Gordon, J Xiang
Cancer Biotherapy and Radiopharmaceuticals 17 (6), 601-619, 2002
1062002
Aptamers, the nucleic acid antibodies, in cancer therapy
Z Fu, J Xiang
Advances in Medical Biochemistry, Genomics, Physiology, and Pathology, 143-175, 2021
1042021
One Hundred Seventy-Fold Increase in Excretion of an FV Fragment-Tumor Necrosis Factor Alpha Fusion Protein (sFV/TNF-α) fromEscherichia coli Caused by the …
J Yang, T Moyana, S MacKenzie, Q Xia, J Xiang
Applied and environmental microbiology 64 (8), 2869-2874, 1998
1041998
Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor
CM Cairns, JR Gordon, F Li, ME Baca-Estrada, T Moyana, J Xiang
The Journal of Immunology 167 (1), 57-65, 2001
1032001
系统目前无法执行此操作,请稍后再试。
文章 1–20